RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Filecoin Foundation and Ava Labs have launched a native cross-chain data bridge that allows Avalanche to offload and verify data on Filecoin.

The cross-chain data storage prototype, implemented by FIL-B and FilOz, demonstrates how data generated on EVM-compatible ...

EA and Caddle power data collaboration options for brands, including shopper insights, audience augmentation and advertising attribution ...

Thousands of professionals from across North, Central, and South America gathered last week in Fort Lauderdale from May 13–15 ...

Trade body Bacta has confirmed the appointment of a new leadership duo as the UK government prepares sweeping reforms to ...

Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing an integrated pipeline of genetic therapies for rare diseases, today announced an update related to ...